India’s First Comprehensive Cancer Multi-Omics Data Portal is a key topic under Social Issues for UPSC Civil Services Examination. Key points include: ICGA launched India's first comprehensive cancer multi-omics data portal.. The portal serves as a repository for India's cancer genomics data.. It provides open access to clinically correlated data from Indian cancer patients.. Understanding this topic is essential for both UPSC Prelims and Mains preparation.
India’s First Comprehensive Cancer Multi-Omics Data Portal is a Medium-level topic in UPSC Social Issues. It is tested in both Prelims (factual MCQs) and Mains (analytical answer writing). Previous year UPSC questions have frequently covered aspects of India’s First Comprehensive Cancer Multi-Omics Data Portal, making it essential for comprehensive IAS preparation.
To prepare India’s First Comprehensive Cancer Multi-Omics Data Portal for UPSC: (1) Study the comprehensive notes covering all key concepts on Vaidra. (2) Practice previous year questions on this topic. (3) Connect it with current affairs using daily updates. (4) Revise using key takeaways and mind maps available for Social Issues. (5) Write practice answers linking India’s First Comprehensive Cancer Multi-Omics Data Portal to related GS Paper topics.

The Indian Cancer Genome Atlas (ICGA) has recently inaugurated a groundbreaking initiative: India’s first comprehensive cancer multi-omics data portal.
This portal serves as a dedicated repository for the vast and complex landscape of the country’s cancer genomics data.
Multi-omics refers to the integrated study of multiple 'omics' datasets, such as genomics (genes), transcriptomics (RNA), proteomics (proteins), and metabolomics (metabolites).
By combining these diverse data layers, researchers gain a more holistic understanding of cancer's molecular mechanisms and progression.
A crucial aspect of this portal is its commitment to providing open access to its extensive dataset.
This accessibility ensures that researchers globally can leverage the data for advanced studies and therapeutic development.
The portal specifically houses clinically correlated data from Indian cancer patients.
This means the genetic and molecular data are linked with clinical information, such as treatment responses, disease stages, and patient outcomes, making it highly valuable for translational research.
This initiative is pivotal for understanding the unique genetic landscape of cancer in the Indian population, which can differ significantly from Western populations.
For UPSC Mains GS-II (Health) and GS-III (Science & Technology), this portal represents a significant leap in India's healthcare infrastructure and scientific research capabilities.


India’s FY 2025-26 GDP 7.7% तक बढ़ा – RBI FY 2026-27 में 6.6% वृद्धि का प्रक्षेपण करता है
5 Jun 2026
India’s FY 2025-26 GDP Grows to 7.7% – RBI Projects 6.6% Growth in FY 2026-27
5 Jun 2026
RBI’s 2025 Climate Finance Directions & Taxonomy Push to Bridge India’s $2.5 trillion Green Gap
5 Jun 2026
PM Modi Announces Jai Prakash Narayan Bird Sanctuary as India’s 100th Ramsar Site
5 Jun 2026